We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App





Academy guidance on data analytics: Preparing clinical labs for a data-driven future

By Jen A. Miller
Posted on 30 Jun 2026

Data analytics is becoming increasingly important for clinical laboratories, but not everyone, or every institution, is at the same stage of their digital transformation. More...

How does someone interested in making their clinical laboratory more data-friendly take the next step? What’s the best way to get involved in a program that’s already started but may be floundering? 

A new guidance document from the Academy of Diagnostics & Laboratory Medicine was created to answer these questions, and a scientific session at ADLM 2026 on July 28 will highlight the key takeaways.

The document, which is currently in the public-comment phase, seeks to help clinical laboratorians figure out how to use its data in a meaningful way, wherever they may be in their data-analytics journey, said Thomas Durant, MD, associate professor of laboratory medicine and biomedical informatics and data science at the Yale School of Medicine, and corresponding author of the Academy Guidance Document. It offers a high-level overview of the essential components required to establish robust data-analytics programs within institutions.

Durant will also present at the ADLM 2026 session, along with Patrick Mathias, MD, PhD, associate professor and associate medical director of the informatics division in the department of laboratory medicine and pathology at the University of Washington School of Medicine in Seattle, Washington; and Sarah Wheeler, PhD, FADLM, CC(NRCC), chair of ADLM’s Data Analytics Steering Committee and associate professor of pathology at the University of Pittsburg, who is also a coauthor of the document.

“Data analytics is one of the things almost all institutions are dealing with now in some way, shape, or form,” Durant said.

“[The Academy Guidance Document addresses] all the big questions that you’re probably going to want to answer when embarking on a data-analytics journey,” Durant added. It’s designed to help people and institutions at different stages on that path, whether they’re still doing work on paper and Excel, or if their institution already has an analytics infrastructure in place.

In their presentation, Durant and team will tackle three main topics:

1.Why to build a data analytics program.

2. What resources are required, including available infrastructure tools and governance policies.

3. How to operate programs with good practice principles, with ethics and patient safety front of mind.

The presenters will make recommendations that will help laboratorians enhance their analytical capabilities and fully leverage their laboratory’s data assets, whether through independent departmental initiatives or collaborative partnerships with their organization’s leadership.

The session will offer something for everyone, Durant said. Participants don’t need to have a background in coding or computer science to attend. In fact, he hopes those who are new to data analytics will come to the session so they can see how accessible today’s tools are for people at all experience levels. “At my institution, some people who use data most in their everyday lives can’t code a lick, but they know their data,” he said. 

Like it or not, institutional change is coming. “It’s really about having someone who’s an analytics champion in the lab,” Durant said. Knowing how to talk to people who can build that architecture can help you communicate your vision, because successful programs require coordinating the people who know how to make that happen.

Overall, Durant hopes this session will help people realize that data analytics is foundational to the future of healthcare. As much as machine learning and artificial intelligence (AI) are hyped as revolutionary technologies, they cannot be implemented without the right data infrastructure in place. “AI is the Ferrari engine, but you have to design this whole fancy car around it to take advantage of it,” he said. The Academy’s new document and the Annual Meeting session will provide that vital framework.


Gold Member
Automatic Hematology Analyzer
CF9600
Online QC Software
Acusera 24•7
Automatic CLIA Analyzer
Shine i6000
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Graphical Abstract (Morgane Fournier et al., Cell (2026). DOI: 10.1016/j.cell.2026.04.013)

Study Reveals Immune Mechanism Driving Severe COVID-19 Progression

Severe COVID-19 has highlighted gaps in understanding of early antiviral responses, particularly why some patients deteriorate despite timely care. Type I interferons are central to host defense, yet their... Read more

Pathology

view channel
Image: Agilent’s PD-L1 IHC 22C3 pharmDx has received EU certification as a companion diagnostic to identify PD-L1–positive ovarian, fallopian tube, or primary peritoneal carcinoma patients eligible for KEYTRUDA (Photo courtesy of Agilent)

PD-L1 Assay Guides Pembrolizumab Eligibility in Ovarian, Fallopian Tube, and Peritoneal Cancers

Agilent Technologies’ PD-L1 IHC 22C3 pharmDx (Code SK006) has received European Union certification as a companion diagnostic to aid in identifying patients with epithelial ovarian, fallopian tube, or... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.